Browse studies

Find your next paid study

25,415 recruiting studies available now

Safety, Efficacy, and Tumor Immune Microenvironment Changes With Neoadjuvant Chemotherapy and Cemiplimab With or Without Alirocumab in Stage 1B-3A Non-Small Cell Lung Cancer: TOP 2301

This study was originally opened on 10/22/2024 as an open-label, two-arm, randomized phase 2 clinical trial, patients with clinical stage 1B-3A non-small cell …

Non Small Cell Lung Cancer

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Duke UniversityNCT06385262

Observational

Evaluation of DNA Methylation Signatures in Diagnosis and Management of Thyroid Nodules

This clinical trial evaluates deoxyribonucleic acid (DNA) methylation signatures in diagnosing and managing thyroid nodules. The purpose of this research is to…

Thyroid Gland Carcinoma

Estimated

~$10 – $750

Actual pay is set by the research site.

City of Hope Medical CenterNCT05229341

Phase 3

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and efficacy of KarXT in male and female subjects …

Psychosis Associated With Alzheimer's Disease

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Karuna Therapeutics, Inc., a Bristol Myers Squibb companyNCT06126224

Phase 3

A Randomized, Open-Label, Phase 3 Study of ZL-1310, a DLL3 Antibody-Drug Conjugate (ADC), Compared to Investigator's Choice Therapy in Participants With Relapsed Small Cell Lung Cancer

The purpose of this study is to evaluate the efficacy and safety of ZL-1310 compared to Investigator's Choice Therapy in participants with relapsed Small Cell …

Small-cell Lung Cancer

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Zai Lab (Shanghai) Co., Ltd.NCT07218146

Observational

Development and Analysis of Weight Loss Programs for Renal Cell Carcinoma Patients on Active Surveillance

This clinical trial compares two different weight-loss programs, daily continuous calorie energy reduction (CER) versus (vs.) 5:2 intermittent fasting (IF), in…

Renal Cell Carcinoma (RCC)

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Roswell Park Cancer InstituteNCT07714018

Phase 2

A Phase 2 Open-Label Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination With Pembrolizumab as First-Line Treatment in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide with an annual incidence of approximately 700,000 cases. This study a…

Head and Neck Squamous Cell Carcinoma

Estimated

~$75 – $3,000

Actual pay is set by the research site.

AbbVieNCT07744126

Observational

Feasibility of MBSR-VR to Reduce Stress Among Emerging Adults With T1D

The goal of this study is to learn if Mindfulness-Based Stress Reduction (MBSR) can be delivered using virtual reality (VR) technology to emerging adults (yout…

Type 1 Diabetes

Estimated

~$10 – $750

Actual pay is set by the research site.

Wayne State UniversityNCT07793097

Clinical and Basic Investigations of Methylmalonic Acidemia (MMA) and Related Disorders

Methylmalonic acidemia (MMA), one of the most common inborn errors of organic acid metabolism, is heterogeneous in etiology and clinical manifestations. Affect…

Organic AcidemiaMethylmalonic AcidemiaInborn Errors of Metabolism

Estimated

~$10 – $675

Actual pay is set by the research site.

National Human Genome Research Institute (NHGRI)NCT00078078

Observational

BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System

The objective of this Investigational Device Exemption trial is to confirm the safety and performance of the LivIQ leadless pacemaker system, in patients with …

Leadless PacemakerBradycardiaAV Block+1 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Biotronik, Inc.NCT07118358

Phase 2

A Single-Arm, Phase 2 Study of Neoadjuvant Carboplatin and Mirvetuximab Soravtansine in Subjects With FRα-Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess the safety and efficacy …

Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer+1 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

AbbVieNCT06890338

Observational

Within-Subject Longitudinal Evaluation of the Cognixion ONE Brain-Computer Interface Speech Generating Device in Individuals With ALS

This study compares a wearable brain-computer interface (BCI) communication device with the eye-tracking communication devices that people with ALS already use…

Amyotrophic Lateral Sclerosis

Estimated

~$10 – $1,125

Actual pay is set by the research site.

CognixionNCT07871071

Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

This study will determine the biochemical and genetic causes of inherited immune diseases affecting lymphocyte homeostasis. Lymphocytes are a type of white blo…

Primary Immune Deficiency

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Allergy and Infectious Diseases (NIAID)NCT00246857